Vaxx Injuries Skyrocket
Mar 12, 2022 1:45:35 GMT -5
Post by maybetoday on Mar 12, 2022 1:45:35 GMT -5
Vaccine-Injuries SKYROCKET: Two Months into 2022, Vaccine-Related Myocarditis Reports in VAERS Have Surged to Nearly Half the Total Reported in 2021
By Julian Conradson
Published March 11, 2022 at 9:43pm
For several months, the US public health regime and the bootlicking media have been routinely downplaying the risk of developing myocarditis after taking the vaccine, calling the occurrence “mild” and “rare,” and systematically burying any evidence to the contrary.
However, myocarditis – a potentially life-threatening inflammation of the heart – is in no way a ‘mild’ adverse reaction to the vaccine – especially when 90% of cases that have been recorded in VAERS ended up hospitalized – so, in other words, that half of the narrative was just an outright lie.
And as for the claim that the condition is ‘rare,’ that was seemingly also completely false. Cases of myocarditis have exploded in the US since the rollout of the experimental vaccine, even in populations that aren’t normally as likely to develop the condition, like children and young adults.
What’s worse – the pace at which otherwise healthy Americans are developing the life-threatening heart condition is speeding up.
According to the most recent Vaccine Adverse Event Reporting System (VAERS) data, the number of myocarditis and pericarditis reports in the first two months of 2022 is already almost half as many as the total number of submissions in 2021.
Daniel Horowitz from The Blaze breaks down the VAERS numbers:
“We are over a year into the known safety signals of this vaccine for myocarditis, and yet the shots still have not been pulled, even for younger males. In fact, it’s still a requirement in many colleges.
Yet reports of myocarditis and pericarditis are so prevalent now that just in the first eight weeks of 2022, we’re already at 47% of the total VAERS submissions for 2021. There were 24,177 reports of pericarditis/myocarditis submitted to VAERS in 2021. In 2022, just through Feb. 25, there were 11,289 reports, which is nearly half of last year’s total.”
Take a look:
Continued at link
By Julian Conradson
Published March 11, 2022 at 9:43pm
For several months, the US public health regime and the bootlicking media have been routinely downplaying the risk of developing myocarditis after taking the vaccine, calling the occurrence “mild” and “rare,” and systematically burying any evidence to the contrary.
However, myocarditis – a potentially life-threatening inflammation of the heart – is in no way a ‘mild’ adverse reaction to the vaccine – especially when 90% of cases that have been recorded in VAERS ended up hospitalized – so, in other words, that half of the narrative was just an outright lie.
And as for the claim that the condition is ‘rare,’ that was seemingly also completely false. Cases of myocarditis have exploded in the US since the rollout of the experimental vaccine, even in populations that aren’t normally as likely to develop the condition, like children and young adults.
What’s worse – the pace at which otherwise healthy Americans are developing the life-threatening heart condition is speeding up.
According to the most recent Vaccine Adverse Event Reporting System (VAERS) data, the number of myocarditis and pericarditis reports in the first two months of 2022 is already almost half as many as the total number of submissions in 2021.
Daniel Horowitz from The Blaze breaks down the VAERS numbers:
“We are over a year into the known safety signals of this vaccine for myocarditis, and yet the shots still have not been pulled, even for younger males. In fact, it’s still a requirement in many colleges.
Yet reports of myocarditis and pericarditis are so prevalent now that just in the first eight weeks of 2022, we’re already at 47% of the total VAERS submissions for 2021. There were 24,177 reports of pericarditis/myocarditis submitted to VAERS in 2021. In 2022, just through Feb. 25, there were 11,289 reports, which is nearly half of last year’s total.”
Take a look:
Continued at link
